These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Wang CZ; Yang SF; Xia Y; Johnson KM Neuropsychopharmacology; 2008 Sep; 33(10):2442-55. PubMed ID: 18059437 [TBL] [Abstract][Full Text] [Related]
3. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex. Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448 [TBL] [Abstract][Full Text] [Related]
4. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat. Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017 [TBL] [Abstract][Full Text] [Related]
5. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Abdul-Monim Z; Neill JC; Reynolds GP J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300 [TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Abekawa T; Ito K; Nakagawa S; Koyama T Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116 [TBL] [Abstract][Full Text] [Related]
7. GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia. Cale JA; Chauhan EJ; Cleaver JJ; Fusciardi AR; McCann S; Waters HC; Žavbi J; King MV Mol Neurobiol; 2024 Sep; 61(9):6968-6983. PubMed ID: 38363536 [TBL] [Abstract][Full Text] [Related]
8. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437 [TBL] [Abstract][Full Text] [Related]
9. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Castañé A; Santana N; Artigas F Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167 [TBL] [Abstract][Full Text] [Related]
10. Neuro-behavioral effects after systemic administration of MK-801 and disinhibition of the anterior thalamic nucleus in rats: Potential relevance in schizophrenia. López Hill X; Richeri A; McGregor R; Acuña A; Scorza C Brain Res; 2019 Sep; 1718():176-185. PubMed ID: 31071305 [TBL] [Abstract][Full Text] [Related]
11. Local blockade of NMDA receptors in the rat prefrontal cortex increases c-Fos expression in multiple subcortical regions. Nowak K; Meyza K; Nikolaev E; Hunt MJ; Kasicki S Acta Neurobiol Exp (Wars); 2012; 72(3):207-18. PubMed ID: 23093008 [TBL] [Abstract][Full Text] [Related]
12. Effects of phencyclidine on immediate early gene expression in the brain. Näkki R; Sharp FR; Sagar SM; Honkaniemi J J Neurosci Res; 1996 Jul; 45(1):13-27. PubMed ID: 8811509 [TBL] [Abstract][Full Text] [Related]
13. Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum. Riebe I; Seth H; Culley G; Dósa Z; Radi S; Strand K; Fröjd V; Hanse E Eur J Neurosci; 2016 Jan; 43(2):169-78. PubMed ID: 26547631 [TBL] [Abstract][Full Text] [Related]
14. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Troyano-Rodriguez E; Lladó-Pelfort L; Santana N; Teruel-Martí V; Celada P; Artigas F Biol Psychiatry; 2014 Dec; 76(12):937-45. PubMed ID: 25038984 [TBL] [Abstract][Full Text] [Related]
15. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine. Reynolds GP; Neill JC J Psychopharmacol; 2016 Nov; 30(11):1141-1144. PubMed ID: 27624147 [TBL] [Abstract][Full Text] [Related]
16. Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1. Radonjić NV; Jakovcevski I; Bumbaširević V; Petronijević ND Psychopharmacology (Berl); 2013 Jun; 227(4):673-83. PubMed ID: 23380917 [TBL] [Abstract][Full Text] [Related]
17. Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat. Griffiths MR; Mitchell IJ; Cooper AJ Brain Res; 1999 Mar; 821(1):177-89. PubMed ID: 10064802 [TBL] [Abstract][Full Text] [Related]
18. Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. Hale MW; Johnson PL; Westerman AM; Abrams JK; Shekhar A; Lowry CA Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1285-93. PubMed ID: 20647026 [TBL] [Abstract][Full Text] [Related]
19. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Cochran SM; Fujimura M; Morris BJ; Pratt JA Synapse; 2002 Dec; 46(3):206-14. PubMed ID: 12325047 [TBL] [Abstract][Full Text] [Related]